← Open Payments lookup

MARKI MEYER: Open Payments

NPI 1710636394 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,354 in 59 payments from 21 companies in 2025. Trend: 2023 $3,234 · 2024 $3,097 · 2025 $1,354

Food & beverage: $1,354
CompanyPaymentsAmount
Novo Nordisk Inc15$235
BETA BIONICS, INC.6$164
Boehringer Ingelheim Pharmaceuticals, Inc.7$153
Dexcom, Inc.3$117
Mannkind Corporation4$80
SANOFI-AVENTIS U.S. LLC2$66
Lilly USA, LLC3$66
RECORDATI_RARE_DISEASES_INC.2$64
Amphastar Pharmaceuticals, Inc.2$49
Xeris Pharmaceuticals, Inc.2$41

Products named: JARDIANCE, Ozempic, iLet Bionic Pancreas, Dexcom G6 Transmitter, AFREZZA, TZIELD, GVOKE HYPOPEN, AZMIRO.

Industry payments across CA — which companies pay providers there.